Recombinant antibodies specific for the Plasmodium falciparum histidine-rich protein 2

mAbs

Volumn 2, Issue 4, 2010, Pages 416-427

  Ravaoarisoa, Elisabeth ^a,b   Zamanka, Halima ^b,c   Fusai, Thierry ^d   Bellalou, Jacques ^e   Bedouelle, Hugues ^e   Mercereau Puijalon, Odile ^b   Fandeur, Thierry ^b,c  

^a INSTITUT PASTEUR DE MADAGASCAR   (Madagascar)

^b CNRS   (France)

^c Centre de Recherche Medicale et Sanitaire   (Niger)

^d SERVICE DE SANTÉ DES ARMÉES   (France)

^e INSTITUT PASTEUR   (France)

Author keywords

Histidine rich protein; Malaria; Monoclonal antibodies; Plasmodium falciparum; Rapid diagnostic test; Recombinant Fab

Indexed keywords

COMPLEMENTARY DNA; HISTIDINE DERIVATIVE; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY F1110; MONOCLONAL ANTIBODY F1546; NUCLEIC ACID; PLASMODIUM FALCIPARUM HISTIDINE RICH PROTEIN 2; PROTOZOAL PROTEIN; RECOMBINANT ANTIBODY; RECOMBINANT ANTIGEN; UNCLASSIFIED DRUG; HRP-2 ANTIGEN, PLASMODIUM FALCIPARUM; PARASITE ANTIGEN; PROTOZOON ANTIBODY; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CYTOPLASM; DIAGNOSTIC TEST; DNA SEQUENCE; DRUG STRUCTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; ANIMAL; BAGG ALBINO MOUSE; BLOOD EXAMINATION; CHEMISTRY; EARLY DIAGNOSIS; GENETICS; IMMUNOLOGY; MALARIA, FALCIPARUM; METABOLISM; MOLECULAR GENETICS; PLASMODIUM FALCIPARUM; PROTEIN ENGINEERING;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; DNA, COMPLEMENTARY; EARLY DIAGNOSIS; ESCHERICHIA COLI; HEMATOLOGIC TESTS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALARIA, FALCIPARUM; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PLASMODIUM FALCIPARUM; PROTEIN ENGINEERING; PROTOZOAN PROTEINS; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY;

EID: 77958517942     PISSN: 19420862     EISSN: None     Source Type: Journal    
DOI: 10.4161/mabs.12438     Document Type: Article

References (42)

1. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005; 434:214-7.
2. Payne D. Use and limitations of light microscopy for diagnosing malaria at the primary health care level. Bull World Health Organ 1988; 66:621-6.
3. Mwangi TW, Ross A, Snow RW, Marsh K. Case definitions of clinical malaria under different transmission conditions in Kilifi District, Kenya. J Infect Dis 2005; 191:1932-9. (Pubitemid 40705402)
4. Olivar M, Develoux M, Chegou Abari A, Loutan L. Presumptive diagnosis of malaria results in a significant risk of mistreatment of children in urban Sahel. Trans R Soc Trop Med Hyg 1991; 85:729-30.
5. Amexo M, Tolhurst R, Barnish G, Bates I. Malaria misdiagnosis: effects on the poor and vulnerable. Lancet 2004; 364:1896-8. (Pubitemid 39536094)
6. Zikusooka CM, McIntyre D, Barnes KI. Should countries implementing an artemisinin-based combination malaria treatment policy also introduce rapid diagnostic tests? Malar J 2008; 7:176.
7. WHO. 2000. New perspectives, malaria diagnosis: report of a joint WHO/USAID informal consultation. Oct 25-27, 1999; WHO/CDS/RBM/2000.14, WHO/MAL/2000.1091, WHO, Geneva (2000).
8. Moody A. Rapid diagnostic tests for malaria parasites. Clin Microbiol Rev 2002; 15:66-78. (Pubitemid 34052582)
9. Wongsrichanalai C. Rapid diagnostic techniques for malaria control. Trends Parasitol 2001; 17:307-9. (Pubitemid 32553741)
10. Beadle C, Long GW, Weiss WR, McElroy PD, Maret SM, Oloo AJ, et al. Diagnosis of malaria by detection of Plasmodium falciparum HRP-2 antigen with a rapid dipstick antigen-capture assay. Lancet 1994; 343:564-8. (Pubitemid 124000793)
11. Taylor DW, Voller A. The development and validation of a simple antigen detection ELISA for Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 1993; 87:29-31. (Pubitemid 23093053)
12. Shiff CJ, Minjas J, Premji Z. The ParaSight-F test: a simple rapid manual dipstick test to detect Plasmodium falciparum infection. Parasitol Today 1994; 10:494-5. (Pubitemid 2162014)
13. Murray CK, Bell D, Gasser RA, Wongsrichanalai C. Rapid diagnostic testing for malaria. Trop Med Int Health 2003; 8:876-83.
14. Forney JR, Magill AJ, Wongsrichanalai C, Sirichaisinthop J, Bautista CT, Heppner DG, et al. Malaria rapid diagnostic devices: performance characteristics of the ParaSight F device determined in a multisite field study. J Clin Microbiol 2001; 39:2884-90.
15. Parra ME, Evans CB, Taylor DW. Identification of Plasmodium falciparum histidine-rich protein 2 in the plasma of humans with malaria. J Clin Microbiol 1991; 29:1629-34.
16. Desakorn V, Dondorp AM, Silamut K, Pongtavornpinyo W, Sahassananda D, Chotivanich K, et al. Stage-dependent production and release of histidine-rich protein 2 by Plasmodium falciparum. Trans R Soc Trop Med Hyg 2005; 99:517-24.
17. Howard RJ, Uni S, Aikawa M, Aley SB, Leech JH, Lew AM, et al. Secretion of a malarial histidine-rich protein (Pf HRP II) from Plasmodium falciparum-infected erythrocytes. J Cell Biol 1986; 103:1269-77.
18. WHO. 2008. Malaria Rapid diagnostic test performance. Results of WHO product testing of malaria RDTs: Round1. www.wpro.who.int/NR/rdonlyres/ED81BDE9- B812-4B80-8408-3A129A6365C4/0/OMSFIND RapportMalaria200900514v25.pdf.
19. WHO. 2006. Towards quality testing of malaria rapid diagnostic tests: evidence and methods. WHO, western Pacific Region, Manila, Philippines.
20. Bell D, Wongsrichanalai C, Barnwell JW. Ensuring quality and access for malaria diagnosis: how can it be achieved? Nat Rev Microbiol 2006; 4:7-20.
21. WHO. Sources and Prices of Selected Products for the Prevention, Diagnosis and treatment of malaria. A joint WHO RBM, UNICEF, UNAIDS PSI,MSH project. http://apps.who.int/medicinedocs/en/d/Js6174e/.
22. Chiodini PL, Bowers K, Jorgensen P, Barnwell JW, Grady KK, Luchavez J, et al. The heat stability of Plasmodium lactate dehydrogenase-based and histidine-rich protein 2-based malaria rapid diagnostic tests. Trans R Soc Trop Med Hyg 2007; 101:331-7. (Pubitemid 46205898)
23. Jorgensen P, Chanthap L, Rebueno A, Tsuyuoka R, Bell D. Malaria rapid diagnostic tests in tropical climates: the need for a cool chain. Am J Trop Med Hyg 2006; 74:750-4. (Pubitemid 46774390)
24. Loo L, Robinson MK, Adams GP. Antibody engineering principles and applications. Cancer J 2008; 14:149-53.
25. Rapley R. The biotechnology and applications of antibody engineering. Mol Biotechnol 1995; 3:139-54.
26. Rock EP, Marsh K, Saul AJ, Wellems TE, Taylor DW, Maloy WL, et al. Comparative analysis of the Plasmodium falciparum histidine-rich proteins HRP-I, HRP-II and HRP-III in malaria parasites of diverse origin. Parasitology 1987; 95:209-27.
27. Lee N, Baker J, Andrews KT, Gatton ML, Bell D, Cheng Q, et al. Effect of sequence variation in Plasmodium falciparum histidine-rich protein 2 on binding of specific monoclonal antibodies: Implications for rapid diagnostic tests for malaria. J Clin Microbiol 2006; 44:2773-8. (Pubitemid 44228570)
28. Brochet X, Lefranc MP, Giudicelli V. IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res 2008; 36:503-8.
29. Carter P, Bedouelle H, Winter G. Improved oligonucleotide site-directed mutagenesis using M13 vectors. Nucleic Acids Res 1985; 13:4431-43.
30. Bedouelle H, Belkadi L, England P, Guijarro JI, Lisova O, Urvoas A, et al. Diversity and junction residues as hotspots of binding energy in an antibody neutralizing the dengue virus. Febs J 2006; 273:34-46.
31. Leke RF, Djokam RR, Mbu R, Leke RJ, Fogako J, Megnekou R, et al. Detection of the Plasmodium falciparum antigen histidine-rich protein 2 in blood of pregnant women: implications for diagnosing placental malaria. J Clin Microbiol 1999; 37:2992-6. (Pubitemid 29391923)
32. WHO. 2010. Guidelines for the treatment of malaria: second edition. www.who.int/malaria/publications/atoz/9789241547925/en/index.html.
33. Perkins MD, Bell DR. Working without a blindfold: the critical role of diagnostics in malaria control. Malar J 2008; 7:5.
34. WHO. 2002. Diagnosis and management of severe malaria. Jun 2002; Trial edition. www.malaria.org.zw/Case/cm26.pdf.
35. Baker J, McCarthy J, Gatton M, Kyle DE, Belizario V, Luchavez J, et al. Genetic diversity of Plasmodium falciparum histidine-rich protein 2 (PfHRP2) and its effect on the performance of PfHRP2-based rapid diagnostic tests. J Infect Dis 2005; 192:870-7. (Pubitemid 41193085)
36. Zerpa NC, Wide A, Noda J, Bermudez H, Pabon R, Noya OO. Immunogenicity of synthetic peptides derived from Plasmodium falciparum proteins. Exp Parasitol 2006; 113:227-34. (Pubitemid 44061786)
37. Versteeg I, Mens PF. Development of a stable positive control to be used for quality assurance of rapid diagnostic tests for malaria. Diagn Microbiol Infect Dis 2009; 64:256-60.
38. Smith KA, Nelson PN, Warren P, Astley SJ, Murray PG, Greenman J. Demystified recombinant antibodies. J Clin Pathol 2004; 57:912-7.
39. Monsellier E, Bedouelle H. Improving the stability of an antibody variable fragment by a combination of knowledge-based approaches: validation and mechanisms. J Mol Biol 2006; 362:580-93. (Pubitemid 44307161)
40. Fandeur T, Bonnefoy S, Mercereau-Puijalon O. In vivo and in vitro derived Palo Alto lines of Plasmodium falciparum are genetically unrelated. Mol Biochem Parasitol 1991; 47:167-78.
41. Trager W, Jensen JB. Human malaria parasites in continuous culture. Science 1976; 193:673-5.
42. Doury JC, Goasdoue JL, Tolou H, Martelloni M, Bonnefoy S, Mercereau-Puijalon O. Characterisation of the binding sites of monoclonal antibodies reacting with the Plasmodium falciparum rhoptry protein RhopH3. Mol Biochem Parasitol 1997; 85:149-59. (Pubitemid 27170214)